Outpatient Follow-up of COPD Patients Receiving Long-term Non-Invasive Ventilation (OCONIV): A Randomized Controlled Trial

Outpatient Follow-up of COPD Patients Receiving Long-term Non-Invasive Ventilation (OCONIV): A Randomized Controlled Trial - OCONIV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00022102

Enrollment

190

Registered

2020-06-03

Start date

2020-06-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J96.1 J44.9

Interventions

Group 1: Outpatient treatment arm In the group of outpatient controls, the control is carried out on the basis of an outpatient appointment, which, similar to the inpatient control, contains an anamne

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - known COPD with respiratory insufficiency and already initiated NIV therapy for at least 3 months - Signed declaration of consent - Patient age = 18 years - Last exacerbation of COPD defined by the current GOLD guideline more than 3 months ago

Exclusion criteria

Exclusion criteria: - Patient age < 18 years - Mental retardation - Missing declaration of consent

Design outcomes

Primary

Measure	Time frame
Quality of life based on the SRI questionnaire after 12 months	—

Secondary

Measure	Time frame
Admission free survival Ventilation quality (BGA during the day) Cost analysis Therapy adherence Mortality	—

Countries

Germany

Contacts

Public ContactSarah Schwarz

Kliniken der Stadt Köln gGmbH

schwarzsa@kliniken-koeln.de0221890718337

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026